The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

A research review published in Human Genomics revealed that darker skin tones can affect certain medications' safety and ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Positive results were announced from the ECZTEND extension study of Adbry in atopic dermatitis who took part in a previous parent trial.

In more serious cases, dry skin can also occur due to aging, medication side effects, and certain underlying conditions. Eczema (atopic dermatitis) is an inflammatory skin condition that causes ...

Over the last 25 years, UConn great Diana Taurasi has been a star on the basketball court while living with the skin condition eczema.

TUESDAY, Oct. 22, 2024 (HealthDay News) -- The skin condition eczema appears to be linked to a serious condition that can end ...

Arcutis Canada Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is ...

Roflumilast cream 0.15% is under review by Health Canada for the treatment of mild to moderate atopic dermatitis (AD) in adults and children ages 6 years and older, supported by clinical results from ...

Qualcomm has canceled its Snapdragon Dev Kit, the miniature Windows on Arm PC that was originally supposed to ship in June. In an email to customers, Qualcomm said the mini PC “has not met our ...